Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Discovery Medicine
|
April 27, 2016
NK cell-based immunotherapies: awakening the innate anti-cancer response
Fernando Souza-Fonseca-Guimaraes
Clinical & Translational Immunology
|
May 7, 2021
New horizons for natural killer cell research in cancer, infection and inflammation
Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
April 10, 2026
Gain-of-function enhancers optimize CAR-NK cell-based anti-cancer immunotherapy
Emma Wong, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
December 4, 2025
Cytokine routing as an overlooked determinant of immune mobilization
Jingchen Zhou, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
April 23, 2026
Highlights of 2025: advancements in natural killer cell biology
Beatriz Aires-Lopes, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
January 23, 2018
A new checkpoint for Natural Killer cell activation
Fernando Souza-Fonseca-Guimaraes, Nicholas D Huntington
Immunology and Cell Biology
|
May 2, 2024
Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy
Pui Yeng Lam, Fernando Souza-Fonseca-Guimaraes
Cancer Discovery
|
August 10, 2013
Myeloid TGF-β responsiveness promotes metastases
Fernando Souza-Fonseca-Guimaraes, Mark J Smyth
Immunology and Cell Biology
|
June 3, 2025
Highlights of 2024: unleashing the power of NK cells-cancer's worst nightmare
Capucine Bourel, Fernando Souza-Fonseca-Guimaraes, Sylvie Lesage
Immunology and Cell Biology
|
April 20, 2026
CAR-NK cell-based therapies: translational and regulatory breakthroughs
Alison Felipe Bordini Biggi, Fernando Souza-Fonseca-Guimaraes
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Discovery Medicine
|
April 27, 2016
NK cell-based immunotherapies: awakening the innate anti-cancer response
Fernando Souza-Fonseca-Guimaraes
Clinical & Translational Immunology
|
May 7, 2021
New horizons for natural killer cell research in cancer, infection and inflammation
Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
April 10, 2026
Gain-of-function enhancers optimize CAR-NK cell-based anti-cancer immunotherapy
Emma Wong, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
December 4, 2025
Cytokine routing as an overlooked determinant of immune mobilization
Jingchen Zhou, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
April 23, 2026
Highlights of 2025: advancements in natural killer cell biology
Beatriz Aires-Lopes, Fernando Souza-Fonseca-Guimaraes
Immunology and Cell Biology
|
January 23, 2018
A new checkpoint for Natural Killer cell activation
Fernando Souza-Fonseca-Guimaraes, Nicholas D Huntington
Immunology and Cell Biology
|
May 2, 2024
Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy
Pui Yeng Lam, Fernando Souza-Fonseca-Guimaraes
Cancer Discovery
|
August 10, 2013
Myeloid TGF-β responsiveness promotes metastases
Fernando Souza-Fonseca-Guimaraes, Mark J Smyth
Immunology and Cell Biology
|
June 3, 2025
Highlights of 2024: unleashing the power of NK cells-cancer's worst nightmare
Capucine Bourel, Fernando Souza-Fonseca-Guimaraes, Sylvie Lesage
Immunology and Cell Biology
|
April 20, 2026
CAR-NK cell-based therapies: translational and regulatory breakthroughs
Alison Felipe Bordini Biggi, Fernando Souza-Fonseca-Guimaraes
Page
of 11